Literature DB >> 6988262

Continuous subcutaneous insulin infusion: a developing tool in diabetes research.

J C Pickup, H Keen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6988262     DOI： 10.1007/BF01228294

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  36 in total

1.  Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology.

Authors:  N ASHTON
Journal:  Am J Ophthalmol       Date:  1957-10       Impact factor: 5.258

2.  Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

3.  Retinal neovascularization, collaterals, and vascular shunts.

Authors:  P Henkind; G N Wise
Journal:  Br J Ophthalmol       Date:  1974-04       Impact factor: 4.638

4.  The role of lactic acid in retinal neovascularization.

Authors:  E Gerke; M Spitznas; O E Brodde
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1976-07-26

5.  Diabetes, diabetic angiopathy, and growth hormone.

Authors:  K Lundbaek; N J Christensen; V A Jensen; K Johansen; T S Olsen; A P Hansen; H Orskov; R Osterby
Journal:  Lancet       Date:  1970-07-18       Impact factor: 79.321

6.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.

Authors:  W V Tamborlane; R S Sherwin; M Genel; P Felig
Journal:  N Engl J Med       Date:  1979-03-15       Impact factor: 91.245

7.  Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas.

Authors:  J Mirouze; J L Selam; T C Pham; E Mendoza; A Orsetti
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

8.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti
Journal:  Br Med J       Date:  1978-01-28

9.  Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

Authors:  G C Viberti; J C Pickup; R J Jarrett; H Keen
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

10.  Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti; A S Rowe
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321
View more
  6 in total

1.  Binding, internalization, and lysosomal association of 125I-glucagon in isolated rat hepatocytes. A quantitative electron microscope autoradiographic study.

Authors:  P Barazzone; P Gorden; J L Carpentier; L Orci; P Freychet; B Canivet
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

2.  Ultrastructural immunocytochemical localization of renin and angiotensin II in the juxtaglomerular cells of the ischemic kidney in experimental renal hypertension.

Authors:  M Cantin; J Gutkowska; J Lacasse; M Ballak; S Ledoux; T Inagami; J Beuzeron; J Genest
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

3.  Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusion.

Authors:  M L Slevin; E M Piall; G W Aherne; A Johnston; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.

Authors:  J C Pickup; P D Home; R W Bilous; H Keen; K G Alberti
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

5.  Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion.

Authors:  J C Pickup; H Keen; G C Viberti; R W Bilous
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-07

Review 6.  The new insulins. Their characteristics and clinical indications.

Authors:  P D Home; K G Alberti
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.